| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $3.2M | -25.6% | +136.2% |
| SG&A Expense | $2.2M | +11.1% | +35.6% |
| Operating Income | -$5.4M | +14.0% | -80.2% |
| Interest Expense | $6K | +0.0% | +19.4% |
| Net Income | -$5.3M | +13.2% | -89.0% |
| EPS (Basic) | -$0.70 | +9.1% | -366.7% |
| EPS (Diluted) | -$0.70 | +9.1% | -366.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $13.1M | -36.2% | -43.4% |
| Current Assets | $16.9M | -22.5% | -28.8% |
| Total Assets | $17.5M | -22.2% | -29.0% |
| Current Liabilities | $1.7M | -43.7% | -33.5% |
| Total Liabilities | $1.9M | -41.1% | -32.9% |
| Stockholders' Equity | $15.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$14.9M | — | — |
| Financing Cash Flow | $10.5M | — | — |
| -28.5% |